Aimei Health SPAC AFJK Shares Explode 125% on Merger Hunt

Introduction

Aimei Health Technology Co. Ltd (ticker: AFJK) is a special purpose acquisition company (SPAC) formed on April 27, 2023, and headquartered in New York, NY. The firm raises capital through an initial public offering to merge with or acquire businesses in the healthcare innovation sector. Aimei Health Technology began trading on the Nasdaq exchange under the ticker AFJK following a $70 million initial public offering.

Corporate Structure

As a blank-check company, Aimei Health Technology operates with a streamlined team focused on merger and acquisition activities. The firm’s leadership comprises professionals with backgrounds in finance, healthcare technology, and corporate governance. Detailed employee counts are not publicly disclosed, consistent with the SPAC model prior to completing a business combination.

Healthcare SPAC by Bruno Guerrero

Developments and News

• On December 23, 2025, AFJK closed at $72.00, reflecting a 124.93% gain from the prior day’s close of $32.00, on a trading volume of 153,332 shares.
• The company filed two Form 8-K reports with the SEC:
  • December 2, 2025 (Items 1.01, 3.03, 5.03, 5.07, 8.01, 9.01)
  • December 8, 2025 (Items 2.03, 9.01)
• Legal advisor Loeb & Loeb LLP represented Aimei Health Technology in its $70 million initial public offering.

Financial and Strategic Analysis

Aimei Health Technology’s intraday market capitalization stood at approximately $220.6 million. Key metrics (trailing twelve months, as of December 19, 2025) include:

• Price/Earnings (P/E) ratio: 180.15
• Earnings per share (EPS): $0.20
• Profit margin: 0.00%
• Return on assets: –1.04%
• Total cash on hand: $2,980
• Levered free cash flow: $269,620
• Enterprise value: $223.99 million
• Price/Book ratio: 5.29

As a SPAC, Aimei Health Technology reports no operating revenue. Its financial profile reflects capital raised for future acquisitions rather than ongoing operations. The P/E ratio indicates market expectations tied to the successful identification and merger with a target company in healthcare technology.

Market Position and Industry Context

AFJK’s share price has traded within a 52-week range of $6.75 to $98.15. Technical indicators place the stock above its 200-day simple moving average, suggesting upward price momentum. With a market cap under $300 million, the company is classified among small-cap SPACs targeting the healthcare sector. Competition arises from other blank-check vehicles seeking mergers in biotechnology, digital health, and medical devices.

tl;dr

On December 23, 2025, AFJK shares increased to $72.00, reflecting a 124.93% change on a volume of 153,332. The company filed two Form 8-K reports in early December and is in search of a merger partner in the healthcare technology sector. Market capitalization is $220.6 million, with no operating revenue reported and a P/E ratio of 180.15. Completion of a definitive business combination will impact future growth.